Sector valuations Protalix BioTherapeutics, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 20:48:10 17/07/2026 BST			5-day change	1st Jan Change
2.385 ^USD	+3.25%		-2.34%	+32.38%

05-13	Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026
05-13	Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	Price to Book (N)	PEG (N)	EV / Sales (N)	EV / EBITDA (N)	EV / EBIT (N)	Dividend Yield (N)	Capi.($)
PROTALIX BIOTHERAPEUTICS, INC.	11.85x	-	-0.03x	-	-	-	-	186M
ELI LILLY AND COMPANY	34.75x	20.82x	0.75x	12.42x	25.87x	26.87x	0.58%	1,043B
JOHNSON & JOHNSON	26.86x	6.72x	-1.72x	6.13x	16.78x	18.44x	2.15%	602B
ABBVIE INC.	33.14x	12662.52x	0.15x	7.52x	15.43x	15.94x	2.7%	449B
ROCHE HOLDING AG	17.71x	6.56x	1.06x	4.39x	10.82x	12.17x	3.02%	327B
NOVARTIS AG	21.31x	6.14x	-28.59x	5.47x	13.24x	14.48x	2.89%	279B
ASTRAZENECA PLC	21.26x	4.98x	0.95x	4.48x	12.39x	13.4x	1.96%	264B
AMGEN INC.	24.37x	18.75x	3.41x	6.42x	11.35x	14.71x	2.71%	201B
GILEAD SCIENCES, INC.	-49.1x	8.6x	0.35x	5.86x	32.41x	64.88x	2.38%	169B
PFIZER INC.	12.77x	1.63x	0.29x	3.12x	7.88x	8.91x	6.86%	143B
VERTEX PHARMACEUTICALS INCORPORATED	27.8x	5.57x	1.97x	8.4x	18.93x	19.84x	-.--%	123B
BRISTOL-MYERS SQUIBB COMPANY	11.75x	5.31x	0.24x	3.22x	8.67x	9.32x	4.16%	124B
SANOFI	11.61x	1.23x	3.28x	2.17x	6.97x	7.93x	5.53%	106B
GSK PLC	12.39x	4.51x	1.04x	2.75x	7.94x	9.1x	3.56%	105B
CHUGAI PHARMACEUTICAL CO., LTD.	23.41x	5.31x	1.36x	7.92x	14.97x	15.67x	1.89%	73.36B
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	40.1x	5.4x	2.19x	9.09x	30.06x	31.16x	0.48%	54.49B
BAYER AG	20.63x	1.67x	-0.13x	1.73x	8.19x	13.75x	0.48%	53.63B
TAKEDA PHARMACEUTICAL COMPANY LIMITED	43.01x	1.15x	23.09x	2.66x	9.41x	26.91x	3.82%	51.98B
HALEON PLC	19.11x	1.93x	4.08x	3.47x	13.01x	14.6x	2.16%	43.95B
Average	19.20x	709.38x	0.72x	5.40x	14.69x	18.78x	2.63%	221.7B
Weighted average by Cap.	23.39x	1,360.49x	-1.06x	7.19x	17.24x	19.96x	2.21%